Skip to content

Clinical trials

Completed Glomerulosclerosis, Focal Segmental trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulosclerosis, Focal Segmental Status: Completed Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20021
20032
20042
20052
20072
20081
20093
20101
20111
20131
20142
20152
20162
20171
20183
20195
20203
20223
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)10
Travere Therapeutics, Inc.4
Vertex Pharmaceuticals Incorporated3
Istanbul University2
Alexion Pharmaceuticals, Inc.1
Amgen1
Biogen1
Bristol-Myers Squibb1
Children's Hospital Medical Center, Cincinnati1
Children's Hospital of Philadelphia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulosclerosis, Focal Segmental46
Proteinuria14
Nephrotic Syndrome13
Nephrosis, Lipoid11
Kidney Diseases8
Glomerulonephritis, IGA7
Renal Insufficiency, Chronic6
Glomerulonephritis, Membranous5
Diabetic Nephropathies4
Glomerulonephritis4

Trials

Showing 51 to 46 of 46. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.